AU Patent

AU2021266715A1 — Boronic acid derivatives and synthesis, polymorphic forms, and therapeutic uses thereof

Assigned to Qpex Biopharma Inc · Expires 2022-11-17 · 3y expired

What this patent protects

Disclosed herein are antimicrobial compounds, polymorphic forms, compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, β-lactamase inhibitors (BLI…

USPTO Abstract

Disclosed herein are antimicrobial compounds, polymorphic forms, compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, β-lactamase inhibitors (BLIs).

Drugs covered by this patent

Patent Metadata

Patent number
AU2021266715A1
Jurisdiction
AU
Classification
—
Expires
2022-11-17
Drug substance claim
No
Drug product claim
No
Assignee
Qpex Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.